Digital Health and Therapeutics
Accelerator Network
COPD360Net’s Mission is to support the development and adoption of novel digital health tools and therapeutics that treat COPD, prevent progression, and improve lives of individuals with COPD and related chronic lung diseases at all stages of disease.
Why COPD360Net?
While important strides have been made in improving the care for those with COPD, the last regulatory approval of a new mechanism of action therapeutic in COPD was in 2011, and drug development remains focused on individuals with moderate to advanced airflow limitation (GOLD 2-4).
In order to advance the development of new medicines, or the repurposing of existing drugs, a new approach is needed. COPD360Net is designed to facilitate, review, and expedite clinical trials for new therapies and digital health tools. In addition, COPD360Net is focused on implementation science – facilitating discovery to delivery.
Ultimately, the network will serve as an accelerator to speed innovation through patient-centered evidence generation and enabling clinical adoption.
What is COPD360Net?
COPD360Net is a network of core COPD Foundation accredited care centers, experts in the field of COPD and related lung disease, and relevant subject matter experts (including a Health Economist assessing Patient preferences and Valuation of the COPDF pipeline, a psychosocial expert studying cognitive impairment in chronic disease, and Primary Care physicians).
COPD360Net is governed by a Steering Committee of clinical lead expert representatives from participating centers, key content experts, and people with COPD and caregivers. The initial pipeline will be selected by the Steering Committee in partnership with the relevant subject-matter experts and the COPD Foundation’s Community Engagement Committee (CenCo), a diverse patient and caregiver committee.
The goals for COPD360Net are to:
- Accelerate the adoption and reimbursement of digital health tools
- Accelerate the development of novel therapies, including promising repurposed or shelved molecules
- Innovate clinical trial designs: target specific COPD sub populations, use new endpoints, and take a mostly remote digital trials approach
- Translate trial findings and patient preference into practice to inform optimal care delivery and reimbursement
All potential proceeds from COPD360Net will be used to support the COPD Foundation mission.
COPD360Net Steering Committee Members
- Ruth Tal-Singer, PhD (EXECUTIVE COMMITTEE CHAIR)
President & Chief Scientific Officer
COPD Foundation
- Brad Drummond, MD (EXECUTIVE COMMITTEE)
Head of COPD360Net Digital Health and Therapeutic Pipeline Working Group
Associate Professor
University of North Carolina at Chapel Hill
- Jerry Krishnan, MD, PhD (EXECUTIVE COMMITTEE)
Head of COPD360Net Care Delivery Science Working
Professor of Medicine and Public Health Associate & Vice Chancellor for Population Health Sciences
University of Illinois at Chicago
Chicago, IL
- Wilson D. Pace, MD (EXECUTIVE COMMITTEE)
Co-Lead of Primary Care and Integrated Practice Working Group
American Academy of Family Physicians
Chief Medical Officer, DARTNet
- Jean Rommes, PhD (EXECUTIVE COMMITTEE)
Head of COPD360Net Patient and Caregiver Engagement Working Group
Patient Representative
West Des Moines, IA
- Juan P. Wisnivesky, MD, DrPH (EXECUTIVE COMMITTEE)
Co-Lead of Primary Care and Integrated Practice Working Group
Society of General Internal Medicine
Professor, Department of Medicine, Icahn School of Medicine at Mount Sinai
- Cara B. Pasquale, MPH (EXECUTIVE COMMITTEE)
COPD360Net Project Lead
COPD Foundation
- Surya Bhatt, MD
Associate Professor
University of Alabama, Birmingham
- Gerard Criner, MD
Chair and Professor, Thoracic Medicine and Surgery
Temple University
Philadelphia, PA
- MeiLan Han, MD, MS
Professor of Medicine in the Division of Pulmonary and Critical Care
University of Michigan
Ann Arbor, MI
- Karin Hoth, PhD, ABPP
Associate Professor of Psychiatry
University of Iowa Carver College of Medicine
Iowa City, IA
- Ravi Kalhan, MD
Professor of Medicine (Pulmonary and Critical Care) and Preventive Medicine (Epidemiology)
Northwestern University
Chicago, IL
- Jill Ohar, MD
Professor, Pulmonary, Critical Care, Allergy, and Immunologic Medicine
Wake Forest Baptist Health
Winston-Salem, NC
- Fernando Martinez, MD
Bruce Webster Professor of Internal Medicine, Professor of Medicine, Professor of Genetic Medicine
Cornell University
New York, NY
- Richard Mularski, MD, MSHS, MCR
COPD Patient-Powered Research Network co-PI Representative
Professor of Health Systems Science, KP Bernard J. Tyson School of Medicine
Clinical Professor of Medicine, OHSU
The Center for Health Research
Kaiser Permanente Northwest, Portland, OR
- Julia F. Slejko, PhD
Assistant Professor
Pharmaceutical Health Services Research
University of Maryland School of Pharmacy
Baltimore, MD
- Robert (Bob) Wise, MD
Professor of Medicine
Johns Hopkins University
Baltimore, MD
COPD360Net Partners
Blue Marble Health
The COPD Foundation and Blue Marble Health, a company with a remote monitoring platform for healthy living, have entered into a strategic alliance to increase access and adherence to pulmonary rehabilitation through a peer supported virtual pulmonary rehabilitation program. Learn more by clicking here.
Who can I contact about COPD360Net?
Cara Pasquale, Project Lead for COPD360Net at cpasquale@copdfoundation.org.
Please note that at this time we are only reviewing proposals for Phase II ready and beyond.